Evolent Health, Inc. (EVH) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1812 NORTH MOORE ST, SUITE 1705 ARLINGTON, VA 22209 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8741 - Management Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 104,203 | 192,825 | 188,200 | 266,280 | 344,348 | 102,815 | |||
| Cash and cash equivalent | 104,203 | 192,825 | 188,200 | 266,280 | 340,490 | 101,008 | |||
| Short-term investments | 3,858 | 1,807 | |||||||
| Restricted cash and investments | 59,295 | 13,768 | 14,492 | 75,685 | 14,437 | 20,080 | |||
| Receivables | 413,346 | 446,220 | 246,209 | 129,012 | 122,167 | 71,707 | |||
| Contract with customer, asset, after allowance for credit loss | 329 | 1,751 | |||||||
| Other undisclosed current assets | 30,273 | 30,860 | 29,153 | 52,983 | 64,853 | 32,448 | |||
| Total current assets: | 607,117 | 683,673 | 478,054 | 523,960 | 546,134 | 228,801 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 6,134 | 11,983 | 49,027 | 50,203 | 57,799 | 72,173 | |||
| Property, plant and equipment | 73,151 | 78,194 | 87,874 | 81,365 | 86,240 | 85,155 | |||
| Long-term investments and receivables | 8,588 | 4,895 | 4,475 | 10,335 | 21,971 | 140,078 | |||
| Long-term investments | 8,588 | 4,895 | 4,475 | 5,458 | 17,417 | 139,369 | |||
| Accounts and financing receivable, after allowance for credit loss | 4,877 | 4,554 | 709 | ||||||
| Intangible assets, net (including goodwill) | 1,817,476 | 1,868,551 | 1,165,558 | 706,081 | 622,806 | 880,523 | |||
| Goodwill | 1,137,320 | 1,116,542 | 722,774 | 426,297 | 354,734 | 572,064 | |||
| Intangible assets, net (excluding goodwill) | 680,156 | 752,009 | 442,784 | 279,784 | 268,072 | 308,459 | |||
| Contract with customer, asset, after allowance for credit loss | 999 | ||||||||
| Capitalized contract cost, net | 13,378 | 12,120 | 17,461 | 32,624 | 26,687 | 36,482 | |||
| Restricted cash and investments | 14,998 | 16,864 | 12,466 | 12,977 | 7,270 | 8,260 | |||
| Other undisclosed noncurrent assets | 3,569 | 4,028 | 2,378 | 1,913 | 1,278 | 45,544 | |||
| Total noncurrent assets: | 1,937,294 | 1,996,635 | 1,339,239 | 895,498 | 824,051 | 1,269,214 | |||
| TOTAL ASSETS: | 2,544,411 | 2,680,308 | 1,817,293 | 1,419,458 | 1,370,185 | 1,498,015 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 162,386 | 198,095 | 168,372 | 255,186 | 164,853 | 105,522 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 51,861 | 48,278 | 34,691 | ||
| Accounts payable | 96,025 | 48,246 | 57,174 | 96,084 | 32,068 | 37,488 | |||
| Accrued liabilities | 66,361 | 149,849 | 111,198 | 107,241 | 84,507 | 33,343 | |||
| Deferred revenue | 2,507 | 5,976 | 5,758 | 11,944 | 14,327 | 19,828 | |||
| Debt | 171,467 | 26,557 | 6,269 | ||||||
| Other undisclosed current liabilities | 379,141 | 470,171 | 259,312 | 178,363 | 196,042 | 61,150 | |||
| Total current liabilities: | 715,501 | 674,242 | 433,442 | 445,493 | 401,779 | 192,769 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 490,520 | 597,049 | 412,986 | 273,398 | 325,869 | 68,858 | |||
| Long-term debt, excluding current maturities | 490,520 | 597,049 | 412,986 | 215,676 | 263,343 | ||||
| Liabilities, other than long-term debt | 38,853 | 56,130 | 68,031 | 6,934 | 22,937 | 15,004 | |||
| Deferred revenue | 1,173 | 2,533 | 1,330 | ||||||
| Deferred income tax liabilities | 10,900 | 13,311 | 4,744 | 1,403 | 728 | 1,942 | |||
| Other liabilities | 2,984 | 3,637 | 4,744 | 5,531 | 22,209 | 11,732 | |||
| Operating lease, liability | 24,969 | 38,009 | 56,010 | 57,722 | 62,526 | 68,858 | |||
| Other undisclosed noncurrent liabilities | 108,105 | 106,759 | 43,417 | 292,337 | |||||
| Total noncurrent liabilities: | 637,478 | 759,938 | 524,434 | 280,332 | 348,806 | 376,199 | |||
| Total liabilities: | 1,352,979 | 1,434,180 | 957,876 | 725,825 | 750,585 | 568,968 | |||
| Temporary equity, including noncontrolling interest | 190,173 | 178,427 | |||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | 1,001,259 | 1,067,701 | 859,417 | 693,633 | 619,600 | 922,358 | |||
| Common stock | 1,166 | 1,154 | 1,015 | 908 | |||||
| Treasury stock, value | (21,123) | (21,123) | (21,123) | (21,123) | (21,123) | ||||
| Additional paid in capital | 1,803,786 | 1,808,121 | 1,486,857 | 1,340,989 | 1,229,320 | 1,173,708 | |||
| Accumulated other comprehensive loss | (1,753) | (1,257) | (1,178) | (362) | (278) | (234) | |||
| Accumulated deficit | (780,817) | (719,194) | (606,154) | (626,779) | (589,178) | (251,962) | |||
| Other undisclosed equity, attributable to parent | 859 | 846 | |||||||
| Equity, attributable to noncontrolling interest | 6,689 | ||||||||
| Total equity: | 1,001,259 | 1,067,701 | 859,417 | 693,633 | 619,600 | 929,047 | |||
| TOTAL LIABILITIES AND EQUITY: | 2,544,411 | 2,680,308 | 1,817,293 | 1,419,458 | 1,370,185 | 1,498,015 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,554,741 | 1,963,896 | 1,352,013 | 907,957 | 1,022,433 | 846,383 | ||
| Cost of revenue | (2,187,388) | (1,503,426) | (1,035,429) | (20,468) | ||||
| Cost of product and service sold | (1,035,429) | |||||||
| Policyholder benefits and claims incurred, net | (20,468) | |||||||
| Gross profit: | 367,353 | 460,470 | 316,584 | 887,489 | 1,022,433 | 846,383 | ||
| Operating expenses | (402,930) | (513,697) | (336,464) | (950,368) | (1,293,057) | (1,152,995) | ||
| Other undisclosed operating income (loss) | (4,908) | (17,984) | 23,522 | 20,468 | ||||
| Operating income (loss): | (40,485) | (71,211) | 3,642 | (42,411) | (270,624) | (306,612) | ||
| Nonoperating income | 5,785 | 4,713 | 1,426 | 261 | 3,045 | 3,495 | ||
| Investment income, nonoperating | 5,544 | 5,256 | 1,369 | 407 | 3,164 | 3,987 | ||
| Other nonoperating income (expense) | 241 | (543) | 57 | (146) | (119) | (492) | ||
| Interest and debt expense | (24,722) | (75,215) | (25,764) | (25,425) | (33,126) | (14,534) | ||
| Loss from continuing operations before equity method investments, income taxes: | (59,422) | (141,713) | (20,696) | (67,575) | (300,705) | (317,651) | ||
| Income (loss) from equity method investments | (3,441) | 1,290 | 4,569 | 13,179 | 10,039 | (9,465) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (173) | (61,982) | (45,950) | 24,595 | (47,133) | |||
| Loss from continuing operations before income taxes: | (63,036) | (202,405) | (62,077) | (29,801) | (337,799) | (327,116) | ||
| Income tax expense (benefit) | 1,413 | 89,365 | 43,376 | (483) | 3,553 | 21,536 | ||
| Loss from continuing operations: | (61,623) | (113,040) | (18,701) | (30,284) | (334,246) | (305,580) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (37,601) | (334,246) | (305,580) | |
| Loss from discontinued operations | (463) | (7,317) | ||||||
| Other undisclosed net loss | ||||||||
| Net loss: | (61,623) | (113,040) | (19,164) | (37,601) | (334,246) | (305,580) | ||
| Net income attributable to noncontrolling interest | 3,609 | |||||||
| Other undisclosed net income attributable to parent | ||||||||
| Net loss attributable to parent: | (61,623) | (113,040) | (19,164) | (37,601) | (334,246) | (301,971) | ||
| Preferred stock dividends and other adjustments | (31,831) | (29,220) | ||||||
| Net loss available to common stockholders, diluted: | (93,454) | (142,260) | (19,164) | (37,601) | (334,246) | (301,971) | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (61,623) | (113,040) | (19,164) | (37,601) | (334,246) | (305,580) | ||
| Other undisclosed comprehensive loss | (84) | (44) | (52) | |||||
| Comprehensive loss: | (61,623) | (113,040) | (19,164) | (37,685) | (334,290) | (305,632) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 3,609 | |||||||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (32,327) | (29,299) | (816) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (93,950) | (142,339) | (19,980) | (37,685) | (334,290) | (302,023) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.